Trius Therapeutics, Inc. (Nasdaq: TSRX) has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE